In the News

​This article by Marie McCarthy and Bob Swann discusses how robust assessments based on digital data are a means of reducing the uncertainty that HTA bodies and payers face in making decisions around advanced therapy medicinal products.

An interview in which Steve Cutler gives a short overview of ICON and describes the company’s role in the Pfizer/BioNTech trial, explaining how the FDA played a critical role in expediting regulatory approvals.

Shelley McLendon, VP of Project Management, Vaccines and Infectious Diseases, outlines best practices that can keep trials running at optimal speed and efficiency, and the benefits of adopting a strategic partnership.

ICON CEO Steve Cutler, discusses running the Pfizer / BioNTech vaccine trial, and how it proved the value of partnership, and the key role of technology.

ICON CEO Steve Cutler has been chosen as The Irish Times Business Person of the Month for February 2021.

ICON's Dr. Andrew Garrett, Executive Vice President of Scientific Operations, weighs in on potential safety issues with the AstraZeneca COVID-19 vaccine.

Dr Nuala Murphy, President of Clinical Services, talks exclusively to Pharmafield about the Pfizer / BioNTech COVID-19 vaccine trial and the implications this has on the future of drug development.

In this interview, Cindy Spittle talks about the women role models who provided inspiration in her career in honour of International Women's Day.

Marelise Epstein is interviewed for International Women's Day and provides a glimpse into her work day and what inspires her.

An interview with CEO Steve Cutler on ICON's recent acquisition of PRA Health Sciences.